ArticleFrontiers in oncology2020

HER3 Differentiates Basal From Claudin Type Triple Negative Breast Cancer and Contributes to Drug and Microenvironmental Induced Resistance.

Nicoleta Sinevici et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.